Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

OBJECTIVES: Chronic hepatitis C virus (HCV) is a leading cause of hospitalization and death in populations coinfected with human immunodeficiency virus (HIV). Sofosbuvir (SOF) is a pan-genotypic drug that should be combined with other agents as an oral treatment for HCV. We performed a 5-year horizo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clinicoecon Outcomes Res
Asıl Yazarlar: Cenderello, Giovanni, Artioli, Stefania, Viscoli, Claudio, Pasa, Ambra, Giacomini, Mauro, Giannini, Barbara, Dentone, Chiara, Nicolini, Laura Ambra, Cassola, Giovanni, Di Biagio, Antonio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706121/
https://ncbi.nlm.nih.gov/pubmed/26770065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S93641
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller